# Study Evaluating Effexor XR in Chinese Subjects With Major Depressive Disorder

> **NCT00878748** · PHASE4 · WITHDRAWN · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer**

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Effexor XR
- **OTHER:** Effexor XR discontinue

## Key facts

- **NCT ID:** NCT00878748
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-04
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2021-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00878748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00878748, "Study Evaluating Effexor XR in Chinese Subjects With Major Depressive Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00878748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*